Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease

Area of Science:

• Hepatology and Nephrology
• Public Health
• Epidemiology

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a primary concern for hepatologists globally, driving research for effective therapies.
• While viral hepatitis treatments have improved, NAFLD's rising incidence makes chronic liver disease a persistent health challenge.
• NAFLD is increasingly linked to severe outcomes like liver cirrhosis and hepatocellular carcinoma, impacting liver transplant lists.

Purpose of the Study:

• To investigate the association between nonalcoholic fatty liver disease and chronic kidney disease.
• To highlight the growing global burden of both NAFLD and chronic kidney disease.

Main Methods:

• Review of recent epidemiological studies and clinical data.
• Analysis of trends in NAFLD and chronic kidney disease incidence and prevalence.
• Examination of documented associations between these two conditions.

Main Results:

• Nonalcoholic fatty liver disease incidence and prevalence are rising globally, posing a significant public health threat.
• Chronic kidney disease also shows increasing incidence and prevalence, associated with high morbidity, mortality, and healthcare costs.
• Multiple studies indicate a clear association between nonalcoholic fatty liver disease and chronic kidney disease.

Conclusions:

• The rising trends of NAFLD and chronic kidney disease underscore their status as major global health problems.
• The established link between NAFLD and CKD warrants further investigation and integrated management strategies.
• Increased awareness and diagnosis are crucial for both underdiagnosed conditions to mitigate future health burdens.